4D Molecular Therapeutics (FDMT) Amortizatization of Intangibles: 2021-2025
Historic Amortizatization of Intangibles for 4D Molecular Therapeutics (FDMT) over the last 5 years, with Sep 2025 value amounting to $1.2 million.
- 4D Molecular Therapeutics' Amortizatization of Intangibles fell 48.48% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year decrease of 5.33%. This contributed to the annual value of $7.2 million for FY2024, which is 364.85% up from last year.
- As of Q3 2025, 4D Molecular Therapeutics' Amortizatization of Intangibles stood at $1.2 million, which was down 1.03% from $1.2 million recorded in Q2 2025.
- In the past 5 years, 4D Molecular Therapeutics' Amortizatization of Intangibles ranged from a high of $2.8 million in Q4 2022 and a low of -$582,000 during Q1 2022.
- Moreover, its 3-year median value for Amortizatization of Intangibles was $1.2 million (2025), whereas its average is $1.1 million.
- Data for 4D Molecular Therapeutics' Amortizatization of Intangibles shows a peak YoY increase of 628.16% (in 2022) and a maximum YoY decrease of 259.45% (in 2022) over the last 5 years.
- Quarterly analysis of 5 years shows 4D Molecular Therapeutics' Amortizatization of Intangibles stood at $380,000 in 2021, then soared by 628.16% to $2.8 million in 2022, then tumbled by 85.15% to $411,000 in 2023, then spiked by 350.12% to $1.9 million in 2024, then plummeted by 48.48% to $1.2 million in 2025.
- Its Amortizatization of Intangibles was $1.2 million in Q3 2025, compared to $1.2 million in Q2 2025 and $1.3 million in Q1 2025.